144 related articles for article (PubMed ID: 22964394)
1. Reversal of experimental Laron Syndrome by xenotransplantation of microencapsulated porcine Sertoli cells.
Luca G; Calvitti M; Mancuso F; Falabella G; Arato I; Bellucci C; List EO; Bellezza E; Angeli G; Lilli C; Bodo M; Becchetti E; Kopchick JJ; Cameron DF; Baroni T; Calafiore R
J Control Release; 2013 Jan; 165(1):75-81. PubMed ID: 22964394
[TBL] [Abstract][Full Text] [Related]
2. A cell therapy-based cure of the Laron Syndrome.
Park K
J Control Release; 2013 Jan; 165(1):90. PubMed ID: 23218447
[No Abstract] [Full Text] [Related]
3. Generation of a miniature pig disease model for human Laron syndrome.
Cui D; Li F; Li Q; Li J; Zhao Y; Hu X; Zhang R; Li N
Sci Rep; 2015 Oct; 5():15603. PubMed ID: 26511035
[TBL] [Abstract][Full Text] [Related]
4. Long-term stability, functional competence, and safety of microencapsulated specific pathogen-free neonatal porcine Sertoli cells: a potential product for cell transplant therapy.
Luca G; Mancuso F; Calvitti M; Arato I; Falabella G; Bufalari A; De Monte V; Tresoldi E; Nastruzzi C; Basta G; Fallarino F; Lilli C; Bellucci C; Baroni T; Aglietti MC; Giovagnoli S; Cameron DF; Bodo M; Calafiore R
Xenotransplantation; 2015; 22(4):273-83. PubMed ID: 26134468
[TBL] [Abstract][Full Text] [Related]
5. First use of gene therapy to treat growth hormone resistant dwarfism in a mouse model.
Sia KC; Gan SU; Mohd Rodhi SH; Fu ZY; Kopchick JJ; Waters MJ; Lee KO
Gene Ther; 2022 Jun; 29(6):346-356. PubMed ID: 35105948
[TBL] [Abstract][Full Text] [Related]
6. Transgenic Wuzhishan minipigs designed to express a dominant-negative porcine growth hormone receptor display small stature and a perturbed insulin/IGF-1 pathway.
Li F; Li Y; Liu H; Zhang X; Liu C; Tian K; Bolund L; Dou H; Yang W; Yang H; Staunstrup NH; Du Y
Transgenic Res; 2015 Dec; 24(6):1029-42. PubMed ID: 26510874
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone insensitivity: diagnostic and therapeutic approaches.
Kurtoğlu S; Hatipoglu N
J Endocrinol Invest; 2016 Jan; 39(1):19-28. PubMed ID: 26062520
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and growth hormone receptor gene mutations of patients with Laron syndrome from a Chinese family.
Ying YQ; Wei H; Cao LZ; Lu JJ; Luo XP
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):335-8. PubMed ID: 17706034
[TBL] [Abstract][Full Text] [Related]
9. Microencapsulation in Clinical Islet Xenotransplantation.
Shimoda M; Matsumoto S
Methods Mol Biol; 2017; 1479():335-345. PubMed ID: 27738947
[TBL] [Abstract][Full Text] [Related]
10. Novel growth hormone receptor gene mutation in a patient with Laron syndrome.
Arman A; Yüksel B; Coker A; Sarioz O; Temiz F; Topaloglu AK
J Pediatr Endocrinol Metab; 2010 Apr; 23(4):407-14. PubMed ID: 20583548
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel mutation in the human growth hormone receptor gene (GHR) in a patient with Laron syndrome.
Gennero I; Edouard T; Rashad M; Bieth E; Conte-Aurio F; Marin F; Tauber M; Salles JP; El Kholy M
J Pediatr Endocrinol Metab; 2007 Jul; 20(7):825-31. PubMed ID: 17849745
[TBL] [Abstract][Full Text] [Related]
12. MECHANISMS IN ENDOCRINOLOGY: Transient juvenile hypoglycemia in growth hormone receptor deficiency - mechanistic insights from Laron syndrome and tailored animal models.
Hinrichs A; Renner S; Bidlingmaier M; Kopchick JJ; Wolf E
Eur J Endocrinol; 2021 Jul; 185(2):R35-R47. PubMed ID: 34048365
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Molecular Features of Laron Syndrome, A Genetic Disorder Protecting from Cancer.
Janecka A; Kołodziej-Rzepa M; Biesaga B
In Vivo; 2016; 30(4):375-81. PubMed ID: 27381597
[TBL] [Abstract][Full Text] [Related]
14. Xenograft of microencapsulated Sertoli cells restores glucose homeostasis in db/db mice with spontaneous diabetes mellitus.
Luca G; Arato I; Mancuso F; Calvitti M; Falabella G; Murdolo G; Basta G; Cameron DF; Hansen BC; Fallarino F; Baroni T; Aglietti MC; Tortoioli C; Bodo M; Calafiore R
Xenotransplantation; 2016 Nov; 23(6):429-439. PubMed ID: 27678013
[TBL] [Abstract][Full Text] [Related]
15. A half-century of studies of growth hormone insensitivity/Laron syndrome: A historical perspective.
Rosenbloom AL
Growth Horm IGF Res; 2016 Jun; 28():46-50. PubMed ID: 26276451
[TBL] [Abstract][Full Text] [Related]
16. Is the Laron mouse an accurate model of Laron syndrome?
Kopchick JJ; Laron Z
Mol Genet Metab; 1999 Oct; 68(2):232-6. PubMed ID: 10527674
[No Abstract] [Full Text] [Related]
17. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse).
Zhou Y; Xu BC; Maheshwari HG; He L; Reed M; Lozykowski M; Okada S; Cataldo L; Coschigamo K; Wagner TE; Baumann G; Kopchick JJ
Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13215-20. PubMed ID: 9371826
[TBL] [Abstract][Full Text] [Related]
18. Encapsulation, in vitro characterization, and in vivo biocompatibility of Sertoli cells in alginate-based microcapsules.
Luca G; Calvitti M; Nastruzzi C; Bilancetti L; Becchetti E; Angeletti G; Mancuso F; Calafiore R
Tissue Eng; 2007 Mar; 13(3):641-8. PubMed ID: 17335402
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid xenotransplantation without immunosuppression in experimental hypoparathyroidism: long-term in vivo function following microencapsulation with a clinically suitable alginate.
Hasse C; Bohrer T; Barth P; Stinner B; Cohen R; Cramer H; Zimmermann U; Rothmund M
World J Surg; 2000 Nov; 24(11):1361-6. PubMed ID: 11038207
[TBL] [Abstract][Full Text] [Related]
20. Clinical, Endocrine, and Molecular Genetic Analysis of a Large Cohort of Saudi Arabian Patients with Laron Syndrome.
Al-Ashwal AA; Al-Sagheir A; Ramzan K; Al-Owain M; Allam R; Qari A; Al-Numair NS; Imtiaz F
Horm Res Paediatr; 2017; 88(2):119-126. PubMed ID: 28743110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
